80 participants
A Study to Evaluate the Efficacy and Safety of Rivoceranib in Participants With Recurrent or Metastatic Adenoid Cystic Carcinoma (ACC)
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-07-30
- Start Date:
- 2020-01-22
- Completion:
- 2023-06-28
Conditions
- Adenoid Cystic Carcinoma
Interventions
- DRUG